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Abstract
B ackgrou nd: Antimicrobial resistance is an increasing problem in developing countries and antibiotic use is 
widespread. Our previous surveys in Java, Indonesia, revealed that most antibiotic use was probably unnecessary or 
ineffective. The aim of this study was to explore a potential connection between resistance and substandard 
antibiotics sold in the area.
M ethods: A cross-sectional field study using the simulated client method was conducted in Surabaya. Five first-line 
antibiotics were requested with or without prescription (OTC). A certified laboratory analysed the drug content 
using validated methods. Possible determinants of substandard quality were explored.
Results: In total, 104 samples from 75 pharmacies, ten drug stores and 39 roadside stalls (kiosks) were obtained. 
Pharmacy employees filled all OTC requests. Three quarters of kiosks sold antibiotics. Antibiotics were dispensed as 
single blister strips or repackaged (16%) without label. Ninety five percent of samples carried the label of 14 
Indonesian manufacturers. The pharmaceutical quality did not meet BP standards for 18% of samples. Deviations 
(less active ingredient) were small. There was no association between low content and type of outlet, sold with or 
without prescription, registration type, price or packaging. Median retail prices of products carrying the same label 
varied up to 20 fold.
Co n clu sio n s: Antibiotics were available OTC in all visited pharmacies and sold in the streets of an Indonesian city. 
Most samples contained an active ingredient. We urge to increase enforcement of existing regulations, including 
legislation that categorizes antibiotics as prescription-only drugs for all types of medicine outlets, to limit further 
selection of antimicrobial resistance.
Background
Antimicrobial resistance is an increasing global crisis in 
developing countries. Antibiotic use, particularly over 
the counter, is widespread. Very little data substantiate 
this problem. We surveyed antibiotic usage and resis­
tance in two areas on Java, Indonesia [1] in individuals 
who visited public healthcare facilities. Those who could 
cite the name and dosing regimens of antibiotics had 
consum ed short courses (median three days) of
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amoxicillin or ampicillin, chloramphenicol, ciprofloxacin, 
cotrimoxazole, and tetracycline. The antibiotics were 
prescribed by doctors in public hospitals (12%), health­
care centers (29%), private practice (36%), and by nurses 
and midwives (6%). Similar antibiotics were self-medi­
cated by 17% of the individuals. Antibiotics were pur­
chased from  comm unity pharm acies, drug stores, 
traditional Chinese medicine prescribers (shinshes) or 
their shops and kiosks (roadside stalls, usually on 
wheels) in the areas surrounding the healthcare facilities. 
Low dosage regimens were reported [2]. Among 3275 
individuals (community 2494, hospital 781), 54% carried
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resistant Escherichia coli. Recent antibiotic use was the 
most important determinant of resistance in both popu­
lations [community: odds ratio (OR) 1.8, 95% confidence 
interval (95% CI) 1.5-2.3; hospital: OR 2.5, 95% CI 1.6­
3.9] [3]. We hypothesized that the low-dose regimens of 
a limited number of classes could have contributed to 
the development of resistance. In addition, if antibiotics 
on the m arket in this area have a low content, this 
would further expose bacteria to low concentrations and 
select for resistance in this population. If, on the other 
hand, som e products are counterfeit and contain no 
antibiotic at all, the conclusions of our studies of the 
association  between use and resistance in the area 
would be invalid.
Substandard and counterfeit anti-infective drugs can 
cause therapy failure because of low dosage or absence 
of active drug, adverse effects through excessive dose or 
the presence of incorrect or toxic ingredients, and emer­
gence of antimicrobial resistance through subtherapeutic 
amounts of the antimicrobial drugs [4]. A substandard 
drug is a drug that fails to meet the specifications upon 
laboratory testing in accordance with the specifications 
it claims to comply with. Drugs can be substandard 
among others because they are produced with low qual­
ity or chemically instable ingredients or stored in inade­
quate conditions. According to the WHO definition, a 
counterfeit drug is one that is deliberately and fraudu­
lently m islabeled with respect to identity, source, or 
both [5,6]. Counterfeit products can contain the correct 
amount, too little or too much of the active ingredient. 
Packaging can provide clues about counterfeiting [7]. 
The problem of substandard and counterfeit drugs is 
particularly prevalent in low-income and developing 
countries. Insufficient regulation and manufacturing 
control are major causes [5]. In the last decade, substan­
dard anti-malarial, antibacterial, and antiviral drugs have 
been reported in South East A sia [8-10]. There are 
plenty of reviews and reflection papers [11-13], but 
recent reliable data on the prevalence of substandard 
drugs are lacking [14]. Recently, experts called for more 
political will and less secrecy and for reporting of the 
manufacturer's name as stated on the packaging [4].
There are very few publications on the quality of anti- 
infective drugs on the market in Indonesia [15,16]. As is 
common in many low-income countries, drugs are pur­
chased in private drug outlets. Silverman et al. and Lee 
et al. stated in 1990 [15] and 1991[17], respectively, that 
in Indonesia, fraudulent drug products may represent 
20-30% of all drug products on the market. However, 
no methodological details were provided. The Indone­
sian Drug and Food Control Agency (BPOM) reported 
that antibiotics are amongst the most commonly coun­
terfeited drugs. In 2003, BPOM discovered 55 counter­
feit medicines being sold in the market. Among them
were amoxicillin 500 mg capsules that contained only 
45.84% of the active ingredient [18]. Drug legislation 
and regulation have improved in Indonesia. In 2003 the 
government updated regulations regarding good manu­
facturing practice for the many local private and state 
companies that produce medicines, mostly generics [19]. 
The law categorizes antibiotics as prescription-only 
drugs to be retailed in pharmacies only [20]. Pharmacies 
and drug stores need a government license. Pharmacies 
are allowed to sell all categories of drugs. Drug stores 
have a limited license and are not allowed to dispense 
prescription-only drugs and narcotics. Kiosks can only 
sell "free drugs", e.g. vitamins and paracetam ol. The 
strategic report Indonesia Pharmaceutical and Health­
care Report Q3 2006  and the M atrix of Drug Quality 
Report (update 2008) m entioned that fake products 
accounted for up to 20-25% of total drug sales [18,21].
One method to study medicine dispensing is to use 
sim ulated clients, a method widely practiced by both 
consumer organisations and researchers [22]. We choose 
this method to obtain independent and unbiased infor­
m ation on availability and quality o f drugs in our 
setting.
In this paper we address the following two questions: 
To what extent are first-line antibiotics available with or 
without prescription in Indonesia, and secondly: what is 
the pharm aceutical quality of the active ingredients 
obtained in these ways?
Methods
Study design
A cross sectional survey of potential retailers of antibio­
tics was conducted within the framework of the AMRIN 
Study [1-3]. The protocol of the AM RIN study was 
approved by the Dr. Soetomo Hospital ethics committee 
(ethical clearance No.5/Panke.KKE/2001 (Surabaya). The 
study area was the city of Surabaya, East Java, in the 
streets surrounding the government hospital and two 
public health centres that had participated in our pre­
vious [2] antibiotic survey. In this survey, 417 users of 
antibiotics cited community pharmacies drug stores, tra­
ditional Chinese medicine prescribers (shinshes) or their 
shops and kiosks (roadside stalls, usually on wheels) as 
providers of the antibiotics that they used. The typical 
profile of the OTC user was adult, male and without 
health care insurance. Therefore, four volunteers (three 
men and one woman) were trained to act as clients pur­
chasing antibiotics in these types of outlets. They 
requested the first-line antibiotics with (pharmacy only) 
or without prescription  (all outlets) by the generic 
name, as is the custom in Indonesia. Prescriptions for 
three-day courses were made by a physician for the pur­
pose of the study and presented by the clients in phar­
m acies only. Unfilled prescriptions were destroyed.
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When questioned, the clients were instructed to cite 
standard symptoms of infection, e.g. fever, cough, pain 
while passing urine, etc.
Sample collection
No reliable list of registered pharmacies, drugstores or 
kiosks of the city of Surabaya was available to us at the 
time of the survey. A field sam pling schedule was 
designed (Figures 1a, b, c). Starting from the govern­
ment hospital and two public health centres that were 
included in the previous survey [2], the four 'clients' had 
to follow a distinct direction (north, west, south, and 
east) and visit each consecutive retailer on the way. 
Each retailer was visited once. A first sample size of 100
purchases was deemed appropriate as a pilot, consisting 
of 20 samples of the most used five first-line antibiotics 
(amoxicillin, chloramphenicol, tetracycline, cotrimoxa- 
zole, or ciprofloxacin) each, with or without a prescrip­
tion. If large differences in content were found, the plan 
would be to increase the sample size. The following 
information was recorded: date of purchase; name and 
address of retailer; type of retailer; obtained with or 
without prescription; storage conditions of the antibio­
tic; type of packaging; delivered with or without infor­
mation leaflet (package insert) or oral instruction, and 
price. After the survey, a list of registered pharmacies 
per district obtained from a local pharmaceutical com­
pany was used to estimate the coverage of our survey.
A B
Figure 1 Study plan and actual sample collection of antibiotics from medicine outlets in areas surrounding public healthcare facilities 
by simulated clients in the city of Surabaya. 1a Itineraries in the area surrounding the public hospitalDr. Soetomo. 1b Itineraries in the area 
surrounding the public healthcare centre Puskesmas Pucang Sewu. 1c Itineraries in the area surrounding the public healthcare centre Puskesmas 
Mojo.
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Analysis of samples
Sam ples were digitally photographed (cam era Nikon 
E7900, 3072 x 2304), including package and information 
leaflet, when available. All samples were used for analysis. 
Assays of tablets and capsules were performed by Farma- 
lyse BV (Zaandam, the Netherlands), an ISO 9001: 2000 
certified laboratory registered in the European Union as a 
pharmaceutical control laboratory for chemical physical 
analyses by license nr 101037. High performance liquid 
chrom atography (HPLC) (Thermo Electro Scientific, 
Breda, The Netherlands) was used. The tests were per­
formed in duplicate and executed in conformity with 
GMP-GCLP guidelines (Annex 14 + 15 GMP guidelines). 
A separate quality assurance unit reviewed the final 
report. For content of active ingredient assays of cotri- 
moxazole, tetracycline, and chloramphenicol the British 
Pharmacopoeia BP2005 monographs and standards were 
used [23], for ciprofloxacin and amoxicillin the United 
States Pharmacopeia USP 29 [24].
Statistical analysis
SPSS for Windows version 13 was used for all analyses. 
Fisher's exact test was used to analyze the association 
between substandard quality (using BP limits) [23] and 
retailer, storage conditions, packaging, stated manufac­
turer, whether the product was registered as generic or 
branded, sold with or without prescription and price (> 
20% above price set by the government). Prices in phar­
macies and kiosks and of generic and branded products 
were compared by the Wilcoxon signed-rank test.
Results
Medicine outlets and availability of antibiotics
Between 7 and 15 April 2006, the four 'clients' requested 
an antibiotic from the potential medicine retailers in the 
city of Surabaya along the 3 x 4  routes of the study 
plan. Figure 1a shows the yield on first route, departing 
from the hospital. Details on the second and third route 
are shown in Figure 1b and 1c. Only one of the first ten 
drug stores and none of the four shinshes/traditional 
Chinese medicine shops encountered sold antibiotics. 
From that moment, sam ples primarily planned to be 
purchased in drug stores or from  shinshes were 
requested without prescription in kiosks or pharmacies. 
According to the list of the licensed community phar­
macies provided by the pharmaceutical company, the 
study sample covered 3-57% of 12 of 31 sub-districts in 
Surabaya. Overall, 12% of the 655 licensed pharmacies 
in Surabaya were visited. All but one was a private phar­
macy and all had air conditioning. Total numbers of 
drug stores, shinshes and kiosks in Surabaya were not 
available, making it impossible to calculate the propor­
tion sam pled for these retailers. In pharm acies, the 
requested amount of product was dispensed from boxes
(blisters) or bottles of 500 to 1000 units. All antibiotics 
and quantities were available, except for one pharmacy 
that dispensed only 17 capsules of chloramphenicol 
instead of 20. In kiosks, the antibiotics were exposed to 
sunlight, average high Indonesian temperatures of 32°C 
and high humidity. In six kiosks the requested number 
of units was not available (four to seven instead of ten 
units). Ten kiosks out of 39 did not sell antibiotics.
Antibiotic samples and dispensing
In Table 1 the characteristics of the purchased antibio­
tics are shown. All sam ples with prescription  were 
acquired from pharmacies. In case of a prescription, 
pharmacy employees copied dose regimens from the 
prescriptions onto a slip of paper and attached it to the 
package. No information leaflets or oral instruction were 
given. In case of purchase without prescription, the cli­
ents were never questioned or referred to a physician. 
Both in pharmacies and kiosks, products with similar 
appearance and packaging (according to visual inspec­
tion and com parison of the high resolution digital 
photographs) were dispensed. Figure 2 shows a blister 
strip of amoxicillin sold in a kiosk. Most samples were 
generic products. Twenty-two percent of chlorampheni­
col, 15% of cotrimoxazole, and 60% of tetracycline sam­
ples were branded generics. Capsules were repackaged 
in small plastic bags, 16% of which did not have a label 
with the drug name or unit dose. For 95% of the sam ­
ples, the tablets and capsules carried the labels of 14 
Indonesian manufacturers (Table 2).
Content assay and analysis
Antibiotic samples were collected and stored in an air­
conditioned room until transportation for analysis to the 
Netherlands in the third week of April 2006. According 
to the BP2005 criteria, one fifth of amoxicillin tablets 
and 5 of 22 tetracycline capsules sam ples contained 
slightly less active substance than required (Table 3). 
Fifty percent of cotrimoxazole tablets had a trimetho­
prim content which was not meeting BP standards; 
deviations were up to 20% of the required amount. 
None of the samples had excess active ingredient. No 
association between low content and type of outlet (p =
0.58), sold with or without prescription  (p = 0.78), 
packaging (p = 0.8) registration type (generic versus 
branded) (p = 0.54) or price (p = 0.33) was observed. 
Substandard antibiotics carried the labels of six manu­
facturers (Table 2). On six out of ten substandard pro­
ducts a legible expiry date was printed on the blister 
package, in all cases beyond January 2008.
Retail prices
In Table 4 a retail price comparison is given, including 
the price set by the government [25]. Generic products
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Table 1 Characteristics of antibiotic products purchased by simulated clients at medicine outlets in Surabaya, 
Indonesia
Antibiotic
samples
Amoxicillin 
500 mg 
(10 tablets) 
N = 20
Chloramphenicol
250 mg 
(20 caps.c)
N = 23
Ciprofloxacin 
500 mg 
(10 tablets) 
N = 19
Co- 
trimoxazole 
480 mg 
(10 tablets) 
N= 20
Tetracycline 
250 mg 
(10 caps.) 
N = 19
Tetracycline 
500 mg 
(10 caps.) 
N = 3
Total 
N = 104
Medicine outlet
pharmacy/kiosk/drug store 9/11/0 19/4/0 17/2/0 20/0/0 8/10/1 2/1/0 75/28/1
Prescription
yes/no 5/15 5/18 5/14 6/14 4/15 1/2 25/79
Packaging
blister/plastic bag 20/0 14/9 19/0 20/0 12/7 2/1 87/17
Registration
generic/branded generic 20/0 18/5 19/0 17/3 7/12 2/1 83/21
Pricea/sample
range 290-5000 150-1000 400-8000 145-870 138-1000 300-750 138-8000
median (IQR)b 500 (313-700) 325 (250-500) 850 (500-850) 223 (200-405) 800 (150-900) 400(300-750) 500 (250-800)
aIn rupiah, interquartile range, cone pharmacy dispensed 17 capsules
were less costly than branded generic products; for 
chloramphenicol, cotrimoxazole, and tetracycline the 
differences were statistically significant. In kiosks, retail 
prices were significantly higher than in pharmacies. In 
pharm acies, there was no association between retail 
price and lack of a prescription (data not shown).
Discussion
This field study showed that, despite existing regula­
tions, five first-line antibiotics could easily be obtained 
without a prescription from medicine retailers in one of
the m ajor cities in Indonesia. These antibiotics were 
available in all community pharmacies visited. All phar­
macies and three quarters of roadside stalls sold antibio­
tics O TC, suggesting that the problem is widespread. 
Apart from cotrimoxazole, most sam ples showed the 
expected amounts of active ingredient.
The availability of antibiotics in other medicine out­
lets, that are not licensed for prescription-only drugs, 
differed. Drug stores hardly retailed any antibiotics. This 
was confirmed by a repeat visit to a few drug stores in 
2007 (data not given). Former actions by the national
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Table 2 Stated manufacturer (city of residence) on blisters and/or logos for 104 samples and substandard content 
assay result
Substandard assay test results/total Total
Stated to be manufactured by (city) Amoxicillin Chloramphenicol Ciprofloxacin Cotrimoxazole Tetracycline
Aditama Raya Farmindo (Surabaya) - - - 1/1 - 1/1
Bernofarm (Sidoarjo) - - 0/3 - - 0/3
Darya Varia Laboratoria (Bogor) - - - - 3/11 3/11
Dexa Medica (Palembang) - - 0/10 - - 0/10
Dumex (Jakartaa) - - - - 1/1 1/1
ERBA/Kalbe Farma (Bekasia) - 0/2 - - - 0/2
First Meditama (Sidoarjo) - - - 0/1 - 0/1
Indofarma (Bekasi) 1/4 0/10 0/2 8/9 0/3 10/28
Kimia Farma (Jakarta) 0/1 0/2 0/1 0/3 0/2 0/9
Landson PT Pertiwi Agung (Jakartaa) - 0/1 - - - 0/1
Phapros (Semarang) 2/14 - - 0/1 0/2 2/17
Saka Farma (Jakartaa) - 0/2 - 0/1 - 0/3
Sanbe Farma (Bandung) - 0/4 0/3 0/3 - 0/10
Yarindo (Serang) 1/1 - - 1/1 - 2/2
Unknown - 0/2b - - 1/3c 1/5
Total 4/20 0/23 0/19 10/20 5/22 19/104
aHead office address, bIn small plastic bags and no text or logo on white/green capsules, cIn plastic bags and no text or logo on red and black caps.; red and 
black caps. "BMF"; yellow and blue capsules “TETRA 500"
Drug and Food Control Agency towards drug stores 
might have been effective. Distribution and sales of illeg­
ally imported drugs is punishable by up to five years of 
imprisonment and a fine of two billion rupiah (around 
140,000 EUR).
One of the reasons for OTC retailing in kiosks could 
be that, having no fixed address, kiosk owners escape 
control. Although there is no medical need for kiosks to
retail antibiotics for the purpose of availability - for 
emergencies 24-hour coverage is given by hospital phar­
macies-, it is clear that kiosks fill a commercial demand. 
Kiosks are convenient because they are numerous in 
urban areas, easily accessible and pose no privacy pro­
blems for the nightly client with e.g. a sexually trans­
mitted disease. Tetracyclines are the m ost frequently 
obtained antibiotics OTC [2]. Consumers may not be
Table 3 Antibiotic content of 104 oral samples purchased in medicine outlets in Surabaya, Indonesia
Antibiotic Required active substance (% , min, max) Number of samples Content of active substance 
mg (%  of stated dosage)/ 
tablet or capsule
Content too lowa
Pharmacy Kiosk/Drug store Min Max N (% )
Amoxicillin 
500 mg tablet
92.5 - 110 9 11 457 (91.4) 481 (96.2) 4 (25)b
Chloramphenicol 
250 mg capsule
95 - 105 19 4 239 (95.6) 260 (104) 0
Ciprofloxacin 
500 mg tablet
95 - 105 17 2 481 (96.2) 506 (101.2) 0
Cotrimoxazole 
400/80 mg tablet 
sulfamethoxazole 
trimethoprim
92.5 - 107.5
92.5 - 107.5
20 0 391 (97.8) 
58 (72.5)
411 (102.8) 
81 (101.3)
0
10 (50)c
Tetracycline 
250 mg capsule
95 - 105 8 10 226 (90.4) 259 (103.6) 5 (23)d
Tetracycline 
500 mg capsule
95 - 105 2 1 503 (100.6) 514 (102.8) 0
aCompared with pharmacopeial limits [23]
bTwo were obtained from a pharmacy; cAll were obtained from a pharmacy; dOne was obtained from a pharmacy
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Table 4 Retail price comparison of the antibiotics
Antibiotics Recom- 
mendeda 
retail priceb
Actual retail priceb per capsule or tablet 
median (IQR)
In pharmacies In kiosks p-value Generic Branded generic p-value
Amoxicillin 403 300 700 0.00 500 Not available -
500 mg tablet (300-400) (500-1000) (313-700)
Chloramphenicol 237 258 875 0.00 254 500 0.00
250 mg capsule (230-470) (563-1000) (224-500) (460-875)
Ciprofloxacin 950 850 5000 0.00 850 Not available -
500 mg tablet (500-1000) (2000-8000) (500-1000)
Cotrimoxazole 205 223 Not available - 220 850 0.00
480 mg tablet (200-405) (200-260) (200-870)
Tetracycline 125 150 900 0.00 150 850 0.00
250 mg capsule (150-200) (800-1000) (150-200) (800-1000)
Tetracycline 266 350 750 0.17 350 750 0.17
500 mg capsule (300-400) (750-750) (300-400) (750-750)
a Maximum retail price set by the Minister of Health in March 2006 [25] 
IQR = interquartile range 
b In rupiah
aware that resistance against tetracyclines in Neisseria 
gonorrhoeae has approached 100% in urban areas since 
the nineties [26]. Kiosk owners used to buy their drugs 
from  wholesalers or drug stores. It now seem s that, 
because of recently tightened control of wholesalers and 
drug stores, kiosk owners obtain sm all quantities of 
antibiotics from nearby pharmacies. Strict enforcement 
of the law for community pharmacies without control­
ling the kiosks might make owners turn to an alternative 
illegal supply chain of anti-infectives again. Illegal 
im port increases the risk of counterfeit products in 
other South East Asian countries [10,27,28]. This study 
confirms the data of our previous survey [2] and state­
ments in the press [29] that Chinese traditional healers 
do not retail antibiotics.
The lack of appropriate labeling and counseling in 
pharmacies can be partly explained by the insufficient 
level of training of pharmacy employees, which does not 
include information on drugs. Other reasons for insuffi­
cient labeling and information could be the practice of 
repackaging large (cheaper) packaged units, without pro­
viding (copies of) information leaflets.
The fact that eight out of nine cotrimoxazole samples 
stated to be manufactured by one local company were 
substandard, out of a total of ten substandard samples, 
points to a production problem. Also, because no pro­
duct carried a date beyond expiration, this was consid­
ered as an unlikely cause of the low content. Although 
exposure to sunlight, average high temperatures of 32°C 
in Indonesia and high humidity could have led to degra­
dation of drugs in kiosks, we found no association of 
substandard content of the products with the type of 
medicine outlet. We cannot prove that the antibiotic 
sam ples were produced by the companies printed on
the labels. However, we have no indication that any of 
the samples were counterfeit drug products. Products 
purchased in licensed pharmacies and kiosks carried the 
same label and all samples contained active ingredients. 
In developing countries that struggle with counterfeit 
drug problems, some samples contained no active ingre­
dient at all, too high or very low amounts [8,10,30]. 
Using similar methods, researchers from Burma found 
the antibiotic content of 21 products to be 13 to 48% 
lower than expected [10]. In Laos People's Democratic 
Republic, ampicillin and tetracycline contained 3 to 32% 
and 8 to 14% less active ingredient than expected [9]. In 
the present study, apart from cotrimoxazole (maximally 
20% less active ingredient), deviations from the BP2005 
limits were small. As little variation in availability and 
active ingredient of the antibiotics was found in the first 
104 samples, this sample size was considered sufficient 
for the total survey. Another recent study in Indonesia 
showed a slightly lower content of rifampicin in pro­
ducts from one out of three manufacturers [16]. There­
fore, we cannot concur with form er published 
statements [15,17,18,21] on fraudulent drugs in Indone­
sia, although we cannot exclude that the situation has 
improved recently or that the situation in Surabaya is 
different from other areas in Indonesia. The regulations 
seem to at least effectively guarantee the presence of 
genuine antibiotics on the market.
Widespread unjustified use of the first line antibiotics 
[2,31] is expected to be the major avoidable contributor to 
increasing resistance. The hypotheses leading to this study 
were whether active ingredient in antibiotics purchased in 
the area was too low or absent. Low active ingredient 
(which might contribute to the development of the resis­
tance of bacteria) was only found for cotrim oxazole
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tablets. Interestingly, the strongest association of antibiotic 
use with resistance found in the community population in 
our previous survey was prior use of cotrimoxazole. It was 
associated with carrying E. coli resistant to any of the 
tested antibiotics (OR 5.5, 95% CI 2.1-14.8) and single tri­
methoprim/sulfamethoxazole resistance (OR 7.5, 95% CI 
2.0-28.0) [3]. However, we should keep in mind that the 
samples of the present study were obtained only in one 
out of the two areas of the previous survey, in a different 
time period and that we have no information on brand/ 
batches that were consumed by the individuals who car­
ried the resistant E. coli.
Prices of antibiotics with similar labels differed widely, 
often exceeding the recommended [19] retail price, except 
for generic amoxicillin and ciprofloxacin (Table 4). Gen­
eric products were less costly than branded products, and 
prices were lower in pharmacies than in kiosks.
This is the first published report in the international 
literature that provides objective information on OTC 
sales and the active ingredient of frequently used oral 
antibiotics in Indonesia. The strengths of the study are 
the large sample size of essential antibiotics from one 
stated country of origin (Indonesia) and the analysis by 
a laboratory using HPLC, which is industry standard for 
testing for the amount of active ingredient. Because of 
the simulated client method, commonly used in similar 
studies to procure drug samples for testing [8,28,30], we 
were able to document real life practices. A more official 
approach of drug quality assurance assessment including 
drug pricing was recently developed by WHO [32]. 
However, this method, which also requests consent of 
the responsible retailers [33], would not have exposed 
the OTC sales problem.
The present study has some limitations. We were not 
able to select pharm acies using random  sam pling 
[8,10,28,30] from an official list of registered pharmacies 
in Surabaya; however, our field survey approach should 
exclude major bias. We assume that, because samples 
and packages of the same antibiotics sold in licensed 
pharmacies and kiosks looked genuine and very similar 
by visual inspection and by comparison of the digital 
photographs, they were not counterfeit. We did not pre­
sent the samples to the stated manufacturing companies 
or to the regulatory authority, which may have more 
experience and/or technology to make this determina­
tion. However, the chairman of the Indonesian Pharma­
cists A ssociation  (ISFI) recently said " that it was 
theoretically im possible for counterfeit drugs to be 
taken up by hospitals or licensed pharmacies because 
they normally obtained their medicines through legal 
distributors" [34]. We were not systematically informed 
about the expiry dates of the samples because this infor­
m ation was m issing for the repackaged products or
absent from the partial blister strips. However, no legi­
ble dates were beyond expiration. We selected the anti­
biotics based on their substantial usage in the area [2], 
not on high cost. Therefore, we cannot generalize our 
findings to all types of antibiotics, since expensive anti­
biotics might be a more interesting target for counterfei­
ters. However, large volumes of inexpensive fakes would 
still provide a worthwhile profit for counterfeiters [4]. 
We think that our findings are relevant for the urban 
areas as very similar antibiotic consumption patterns 
were found in the other city of our survey on Java [2]. 
In addition, the stated manufacturers were Indonesian 
companies from 9 different cities of Java or Sumatra 
which are the main islands. Whether the results are true 
for rural areas or small islands of Indonesia remains to 
be seen. We analyzed two oral dosage forms only and 
did not try to study liquid preparations. Our analysis in 
terms of quality was limited to the content, since we did 
not perform analyses of impurities or excipients which 
determine the biological equivalence [24]. We did not 
perform dissolution tests [35] which would assess the in 
vitro availability of the drug. We did not perform follow 
up experiments to determine whether the samples from 
the kiosks, being exposed to heat and humidity, would 
be degraded before the expiry date.
Finally, in concert with other published data from the 
AMRIN study [1-3,31] that provided information on beha­
vioral, cultural and socioeconomic determinants driving 
antimicrobial use and resistance on the level of the pre- 
scriber and user, this study helps to fill the knowledge gap 
of determinants on the level of government health policies 
and the health care system in which they are implemented 
in Indonesia. The W orld Health Organization Global 
Strategy for the Containment of Antimicrobial Resistance 
report [36] states that "National commitment to under­
stand and address the problem and the designation of 
authority and responsibility are prerequisites for interven­
tions. Effective action requires the introduction and enfor­
cement of appropriate regulations.”
Conclusions
Despite these limitations, we conclude that OTC retail­
ing of five first-line oral antibiotics was widespread in 
pharmacies and in kiosks of a major city on Java, Indo­
nesia, often at very high prices. The active ingredient 
was lowest for trimethoprim in cotrimoxazole tablets, 
which m ost likely was related to manufacturing pro­
blems. We recommend increased enforcement of exist­
ing regulations for all types of medicine outlets by the 
national Drug and Food Control Agency, better training 
of pharmacy personnel, control of antibiotic production 
on a national level by local industries and pricing 
according to WHO expert reports [32,33].
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